Patents by Inventor Hartmut Rokos

Hartmut Rokos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5698408
    Abstract: Pterin derivatives having the general formula I ##STR1## wherein R.sub.1 represents a group --(CHOH).sub.2 --CH.sub.3 or --(CHOH).sub.2 --CH.sub.2 OH,R.sub.2 and R.sub.3 are not the same and represent either hydrogen or the group --(CH.sub.2).sub.3 CONH(CH.sub.2).sub.4 --NH--R.sub.4, wherein R.sub.4 represents hydrogen or a usual label group for immunoassays or usual coating/support materials for solid phase immunoassays or immunogenic groups for the preparation of antibodiesare useful for the preparation of sensitive immunoassays for the determination of neopterin and biopterin.
    Type: Grant
    Filed: November 2, 1995
    Date of Patent: December 16, 1997
    Assignee: B.R.A.H.M.S. Diagnostica GmbH
    Inventor: Hartmut Rokos
  • Patent number: 4837229
    Abstract: 5-Aminosalicylic acid O-sulfates of physiologically acceptable bases are new substances which are preparable by esterification of 5-nitrosalicylic acid alkyl esters with carbodiimide and sulfuric acid, alkaline saponification of the alkyl ester group and reduction of the thus obtained 5-nitrosalicylic acid O-sulfates. Said substances are useful as drugs, more specifically for the treatment of colitis ulcerosa, enteritis regionalis Crohn (morbus Crohn), chronic nonspecific colitis and diverticulitis.
    Type: Grant
    Filed: July 25, 1988
    Date of Patent: June 6, 1989
    Assignee: Henning Berlin GmbH Chemie- und Pharmawerk
    Inventors: Hartmut Rokos, Heinz Konczak, Wolfgang Forth
  • Patent number: 4455305
    Abstract: Salicylazobenzoic acid is more useful than salazosulfapyridine for the treatment of colitis ulcerosa, enteritis regionalis (Morbus Crohn), chronic nonspecific colitis and diverticulitis. Salicylazobenzoic acid is used in the form of tablets and dragees or enemae in which it may be used in the form of free acid, compatible salts or mixtures thereof.
    Type: Grant
    Filed: July 9, 1981
    Date of Patent: June 19, 1984
    Assignee: Henning Berlin GmbH Chemie- und Pharmawerk
    Inventor: Hartmut Rokos
  • Patent number: H1018
    Abstract: 1. Immunological method for the determination of free substances having hapten properties.2.1. Immunological methods for the determination of free substances having hapten properties, especially of free thyroid hormones, are based on various determination principles, all of which either have disadvantages from the practical viewpoint or, by reason of the basic principle of the method, provide limited information in marginal cases. The new method is intended to simplify and improve the routine clinical determination of free substances, because of the avoidance of sources of error associated with known methods, while having a procedure which is straightforward for practical use.2.2.
    Type: Grant
    Filed: August 15, 1988
    Date of Patent: January 7, 1992
    Assignee: Henning Berlin GmbH Chemie- und Pharmawerk
    Inventors: Uwe Hantke, Rudy Thoma, Hartmut Rokos, Andre Gadow